Fusion event
HBV-SHLD2P3 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGG| |TCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTT
End
47404204/47714184 (Hg38)
Location type
ncRNA_intronic
Nearest miRNA
hsa-mir-1265/Upstream/2550096; hsa-mir-107/Downstream/1271328;
Upstream sequence
AATAAAATCCCAAACAACTGGTTGTCCGCTAAAATGTTAACTGCTTATTTAGGGTGTTGAGATTATGGCTGCTATATGTTTATTTACTTGGCTTCTCTTA
Downstream sequence
GCTTACTTTTCTAATCAGGTATTTTGTAATAAGACAAGAAAGCTATTTTAGTGATTGGTTTTAAGCAGTAACTTGGAATATATGCTTTAGTTCTAGCTAG
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.